ThinkSabio Latest News
NeurAxis Receives FDA 510(K) Clearance For IB-Stim For Treatment Of Pediatric FAP Associated With Functional Dyspepsia, And FD Related Nausea Symptoms
LightDark
NeurAxis Receives FDA 510(K) Clearance For IB-Stim For Treatment Of Pediatric FAP Associated With Functional Dyspepsia, And FD Related Nausea Symptoms